Looking for breakthrough ideas for innovation challenges? Try Patsnap Eureka!

Oseltamivir warning structure impurity and preparation method thereof

A technology of oseltamivir and impurities, applied in the field of drug synthesis, can solve problems such as increasing the risk of safe drug use, and achieve the effect of high yield

Pending Publication Date: 2022-05-10
ZEIN BIOTECHNOLOGY CO LTD
View PDF4 Cites 4 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

[0006] The limit of warning structural impurities in drugs is usually determined according to the maximum daily dose, generally at the ppm level. The existence of warning structural impurities greatly increases the risk of safe drug use. It is of great significance to effectively control the quality of related preparations

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Oseltamivir warning structure impurity and preparation method thereof
  • Oseltamivir warning structure impurity and preparation method thereof
  • Oseltamivir warning structure impurity and preparation method thereof

Examples

Experimental program
Comparison scheme
Effect test

Embodiment 1

[0036] Example 1 Synthesis of Oseltamivir Warning Structure Impurity (I)

[0037] At room temperature, add 5.00 g of compound (II) (13.79 mmol), ethanol (50 mL) to the reaction flask, stir to dissolve, and cool to 0-10 ° C, add 1.1 g of sodium hydroxide (27.50 mmol) in 10 ml of aqueous solution, Stir overnight at 0-10°C, distill the reaction solution to dryness at 50°C under reduced pressure, add 10ml of dichloromethane and 10ml of water to the residue, add concentrated hydrochloric acid dropwise to adjust the pH=6-7, oily matter is precipitated, and the oily matter is separated Purified by column chromatography, the eluent was petroleum ether: ethyl acetate = 10:1 (volume ratio), and 3.23 g of oseltamivir warning structure impurity (I) was obtained with a yield of 71.1% and a purity of 99.5%.

[0038] MS [M+H]: 282.2.

[0039] 1 H-NMR (600MHz, CD 3 OD) δ0.91(t, 3H), δ0.97(t, 3H), δ1.04(s, 6H), δ1.56(m, 4H), δ2.21(d, 1H), δ2.43 (d, 1H), δ2.57(t, 2H), δ3.46(m, 1H), δ4.20(s,...

Embodiment 2

[0040] Example 2 Synthesis of oseltamivir warning structure impurity (I)

[0041] At room temperature, add 5.00g of compound (II) (13.79mmol), methanol (50mL) to the reaction flask, stir to dissolve, and cool to 0-10°C, add 1.2g of potassium hydroxide (21.43mmol) in 20ml of aqueous solution, Stir overnight at 0-10°C, distill the reaction solution to dryness at 50°C under reduced pressure, add 10ml of dichloromethane and 10ml of water to the residue, add concentrated hydrochloric acid dropwise to adjust the pH=6-7, oily matter is precipitated, and the oily matter is separated Purified by column chromatography, the eluent was petroleum ether: ethyl acetate = 10:1 (volume ratio), and 3.14 g of oseltamivir warning structure impurity (I) was obtained with a yield of 69.3% and a purity of 99.8%.

Embodiment 3

[0042] Example 3 The detection method of the oseltamivir warning structure impurity (I) in the product

[0043] Instruments and equipment: liquid chromatograph, electronic balance, volumetric flask

[0044] Chromatographic conditions:

[0045]

[0046]

[0047] Determination:

[0048] Blank solution: 50% acetonitrile

[0049] Reference substance solution: accurately weigh an appropriate amount of impurity (I) reference substance, dilute it with a blank solution to make about 10 μg / ml, and prepare 2 parts in parallel;

[0050] Test product solution: Accurately weigh an appropriate amount of oseltamivir test product, dilute it with a blank solution to make a 1mg / ml solution, and prepare 2 parts in parallel.

[0051] Quantitation limit: 0.05ug / ml

[0052] Detection limit: 0.017ug / ml

[0053] Sample detection result: lower than the detection limit (see the detection spectrum image 3 , Figure 4 )

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

PUM

No PUM Login to View More

Abstract

The invention discloses an oseltamivir warning structure impurity and a preparation method thereof. The oseltamivir warning structure impurity is shown as a formula I in the specification. The preparation method disclosed by the invention is low in cost and simple and convenient to operate, can be used for large-scale synthesis, and provides a reference substance for qualitative and quantitative analysis of oseltamivir warning structure impurities, thereby laying a solid foundation for quality research of oseltamivir crude drugs and related preparations.

Description

technical field [0001] The invention belongs to the technical field of medicine synthesis and relates to a preparation method of an antiviral medicine oseltamivir impurity. Background technique [0002] Oseltamivir is a specific inhibitor of neuraminidase, which inhibits the action of neuraminidase and can inhibit the mature influenza virus from leaving the host cell, thereby inhibiting the spread of influenza virus in the human body To play a role in the treatment of influenza. Oseltamivir is a successful case of structure-based rational drug design. A large number of computer-aided drug design methods have been used in the research and development of this drug. According to the three-dimensional structure of the target enzyme, a specific drug with high efficiency and low toxicity has been designed. Potent neuraminidase inhibitor. [0003] Patent CN1759093A reports that the synthetic route of oseltamivir is as follows: [0004] [0005] Among them, the hydrolysis of c...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

Application Information

Patent Timeline
no application Login to View More
Patent Type & Authority Applications(China)
IPC IPC(8): C07D203/26G01N30/02G01N30/04
CPCC07D203/26G01N30/02G01N30/04G01N2030/027G01N2030/047
Inventor 肖玉梅代毅牟祥王文静罗奎李玉芳邓祥林
Owner ZEIN BIOTECHNOLOGY CO LTD
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Patsnap Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Patsnap Eureka Blog
Learn More
PatSnap group products

Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic, Popular Technical Reports.

© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap|About US| Contact US: help@patsnap.com